We offer a wide range of preclinical services to evaluate the safety, efficacy, PK, and toxicology of antivirals, drugs, antibodies, and vaccines
Cerba Research is your premier destination for preclinical research services, specializing in virology and immunology. As a leading NIH (National Institutes of Health) approved CRO and clinical trial specialty lab and operation services company, we offer a comprehensive range of preclinical services aimed at testing the safety, effectiveness, pathogenicity, and pharmacokinetics (PK) of various therapeutics such as antivirals, immunomodulators, drugs, antibodies, and vaccines designed to combat infectious diseases.
With an extensive track record in the field, we possess the expertise to work with a multitude of viral targets, including Influenza, HSV, RSV, hMPV, MERS Coronavirus, SARS-CoV, SARS-CoV-2, Varicella Zoster Virus, Measles Virus, Dengue Virus, Monkeypox Virus, Rabies Virus, Polio Virus, Parainfluenza, Highly Pathogenic Avian Influenza, and more.